← SynDRA
SYN2046978
SynDRA canonical compound SYN2046978 — structure-anchored drug synonym record
Clinical phase
Preclinical
Primary target(s)
ADRA1A | ADRA1B | ADRA1D | ADRA2A | ADRA2B | ADRA2C | CACNA1C | CACNA1D
Mechanism of action
adrenergic receptor antagonist
All known targets
ADRA1A
ADRA1D
ADRA1B
ADRA2A
ADRA2B
ADRA2C
CACNA1C
CACNA1D
Mechanisms of action (all sources)
ADRA1A ANTAGONIST
ADRA1D ANTAGONIST
adrenergic receptor antagonist
ADRA2B INHIBITOR
ADRA1A INHIBITOR
ADRA2C INHIBITOR
CACNA1D INHIBITOR
ADRA1D INHIBITOR
CACNA1C INHIBITOR
ADRA1B INHIBITOR
ADRA2A INHIBITOR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ADA1A
ADRA1A
ADRA1B
ADRA1D
ADRA2A
ADRA2B
ADRA2C
Cross-references
PubChem CID:
5311437
ChEMBL:
CHEMBL179334
TTD: D06HRY
Synonyms
SNAP5089
GTPL498
SCHEMBL5165068
(-)-SNAP-5089
SNAP-5089
methyl (4R)-5-[3-[4,4-di(phenyl)piperidin-1-yl]propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
2,6-Dimethyl-4alpha-(4-nitrophenyl)-5-[[3-(4,4-diphenylpiperidino)propyl]carbamoyl]-1,4-dihydro-3-pyridinecarboxylic acid methyl ester
MS-32842
AKOS040745367
FIIXCJGBCCCOQQ-UHFFFAOYSA-N
SNAP5089 hydrochloride
BRD-A21428877-003-02-7
AC1NSKMU
orb1704050
CS-0083446
BRD-A21428877-003-01-9
orb1739043
HGA06677
SNAP5089 (Free base)
methyl (4R)-5-[3-(4,4-diphenylpiperidin-1-yl)propylcarbamoyl]-2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
ZINC100002054
AKOS024457075
MS-33283
L000567
SCHEMBL5919546
NCGC00167733-01
T23374
Look up SYN2046978 in the interactive SynDRA portal →